Sir Ronald Cohen
Co-Founder @ Apax Partners
London, United Kingdom
Sir Ronald Cohen is a Series A investor at Apax Partners in London focused on Health Care and Software. Ronald Cohen is Chairman of the Global Social Impact Investment Steering Group and The Portland Trust. He is a co-founder director of Social Finance UK (2007-11), Social Finance USA, and Social Finance Israel, and of Big Society Capital. He was co-founder Chair of Bridges Ventures (2002-2012).He chaired the Social Impact Investment Taskforceestablished under the UK’s presidency of the G8 (2013-2015), the Social Investment Task Force (2000-2010) and the Commission on Unclaimed Assets (2005-2007). In 2012 he received the Rockefeller Innovation Award for innovation in social finance.He co-founded and was Executive Chairman of Apax Partners Worldwide LLP (1972-2005). He was a founder director and Chairman of the British Venture Capital Association and a founder director of the European Venture Capital Association.He is a graduate of Oxford University, where he was President of the Oxford Union. He is an Honorary Fellow of Exeter College, Oxford. He has an MBA from Harvard Business School to which he was awarded a Henry Fellowship.He is a member of the Board of Dean’s Advisors at Harvard Business School and Vice-Chairman of Ben Gurion University. He is a former director of the Harvard Management Company and the University of Oxford Investment Committee. He is a former member of the Harvard University Board of Overseers (2007-2013), former Trustee of the British Museum (2005-2012) and a former trustee of the International Institute for Strategic Studies (2005-2011).In 2007, Sir Ronald published: “The Second Bounce of the Ball – Turning Risk into Opportunity”.
- Total investments:
- 24
- Last investment:
- Lead investor:
- 4%
Last updated:
For AI agents: llms.txt
Industries Sir Ronald Cohen invests in
Stages Sir Ronald Cohen invests in
Countries Sir Ronald Cohen invests in
Round sizes
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Round size
- Seed
- $3M–$100M
- Series A
- $1.7M–$30M
- Venture - Series Unknown
- $22M–$100M
Investment Focus
Industry
- Health Care 5 (21%)
- Software 4 (17%)
- Financial Services 4 (17%)
- Apps 3 (13%)
- SaaS 3 (13%)
Stage
- Series A 8 (33%)
- Seed 4 (17%)
- Venture - Series Unknown 3 (13%)
- Series B 2 (8%)
- Funding Round 2 (8%)
Country
- Israel 8 (33%)
- United States 6 (25%)
- United Kingdom 2 (8%)
- Poland 1 (4%)
- Switzerland 1 (4%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| MillTechFX is not a market maker, venue, broker or bank.MillTechFX is an independent FXaaS (FX-as-a-service) enabling best execution. Its one-stop currency marketplace allows you to manage all your global FX activity: independent, transparent and tech-enabled.Designed specifically for Fund Managers, Institutional Investors, Corporates andGlobal Businesses, we aim to significantly reduce FX and hedging costs by giving you direct access to preferential currency rates and credit from 10+ Tier 1 counterparty banks. The offering includes:• Hedging, settlement & margin management • Centralising FX activity & reporting in a single platform • Undertaking of regulatory trade reporting, administrator reporting & reconciliation • Demonstrating best execution & total cost transparency with ongoing & independent Transaction Cost AnalysisSeeking fairer, more transparent and cost-effective FX solutions. | $60M / Private Equity / Apr 08, 2026 | ||
| Glide Identity provides SIM-based cryptographic authentication and verification systems using telecom network APIs. It replaces traditional methods like passwords and SMS-OTP by using SIM-anchored cryptographic verification, carrier-network intelligence, and biometrics. Its flagship product, MagicalAuth, verifies users silently via their SIM cardswith no codes or clicks, helping prevent SIM swap attacks, phishing, and other common fraud vectors. | $20M / Series A / Oct 13, 2025 | ||
| Opmed.ai is an innovative provider of cutting-edge technologies and services that offers solutions for hospitals and health care providers. | $15M / Series A / May 06, 2024 | ||
| Selina is one of the world’s fastest growing hospitality brands, combining beautifully-designed accommodation with coworking spaces, wellness, recreational offerings and local experiences for today’s nomadic traveler to live, work and explore anywhere in the world.With a design-centric, technology-first and socially-minded approach to travel,Selina currently operates 24 urban, beach, jungle and mountain-side locations across eight countries and is developing a global infrastructure for nomads who want to make the world their classroom, office, and playground. | $54M / Post-IPO Equity / Oct 27, 2022 | ||
| Circles is a revolutionary emotional support platform that ensures no one has to overcome life’s challenges alone. Circles enables people to be heard, understood and supported by others who are going through the same issues in their lives, such as the loss of a loved one, parenting issues or divorce. By connecting users in safe, intimate andprivate groups led by professional facilitators, Circles helps people heal. Circles groups meet live for 60-minute video meetings and also have the ability to message via online chat at any time. Circles users can also access personalized content, including self-help exercises, blogs and webinars, all at no extra cost. To learn more about Circles or to sign up for a free trial, visit circlesup.com. | $16.5M / Series A / May 24, 2022 | ||
| Masterschool is an applied education research lab on a mission to unlock human potential. | $100M / Seed / May 18, 2022 | ||
| RiseUp is a purpose driven FinTech company making it easier for you to enjoy financial wellbeing. The one place where you can really understand how to spend and save money, giving you ‘financial coaching support’ that helps you make better financial decisions, and a vibrant community of tens of thousands of people where advice, help and learningsare celebrated to propel your growth! | $30M / Series B / Apr 12, 2022 | ||
| Alpha Tau Medical is an Israeli medical device company that focuses on research, development and commercialization of Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) for the treatment of solid cancer. The Alpha DaRT technology was developed in 2003 at Tel Aviv University.Since then, numerous preclinical trials have found the technology tobe effective and safe for various indications and anatomic areas.The findings were published in 12 papers in peer-reviewed scientific journals. Today, the company is running its first clinical trial with very promising preliminary results. | $92M / Post-IPO Equity / Mar 07, 2022 | ||
| Empathy is a platform for families to deal with the loss of their people. Empathy combines technology and human support to provide a digital companion application built to empower bereaved families. The company's flagship offering is a multi-platform app that guides users through the emotional and practical aspects following the loss of aloved one. This includes assistance with tasks such as funeral planning, closing accounts, and managing estate affairs. Empathy's approach is designed to reduce the complexity and stress associated with these responsibilities. | $30M / Series A / Sep 30, 2021 | ||
| Circles is a revolutionary emotional support platform that ensures no one has to overcome life’s challenges alone. Circles enables people to be heard, understood and supported by others who are going through the same issues in their lives, such as the loss of a loved one, parenting issues or divorce. By connecting users in safe, intimate andprivate groups led by professional facilitators, Circles helps people heal. Circles groups meet live for 60-minute video meetings and also have the ability to message via online chat at any time. Circles users can also access personalized content, including self-help exercises, blogs and webinars, all at no extra cost. To learn more about Circles or to sign up for a free trial, visit circlesup.com. | $8M / Seed / Aug 17, 2021 | ||
| See all 24 investments → | |||
Co-Investors
About Apax Partners
Apax Partners is an independent partnership, focused solely on long-term investment in growth companies.
Apax Partners Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Ashish Karandikar
Partner
|
|||
David Marks
Partner and Senior Tax Adviser
|
|||
George Jiao
Vice President
|
|||
Giancarlo Aliberti
Partner
|
|||
Jason Wright
Equity Partner, Tech & Telco
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Sir Ronald Cohen invest in?
Sir Ronald Cohen invests primarily in Health Care, Software and Financial Services startups, most often at Series A and Seed stage. Most of the 24 investments tracked by Shizune back companies in Israel. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Sir Ronald Cohen invest in?
Sir Ronald Cohen typically joins rounds of $3M–$100M at Seed, $1.7M–$30M at Series A and $22M–$100M at Venture - Series Unknown. These are whole funding-round sizes, not Sir Ronald Cohen's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Sir Ronald Cohen took part in.
How do I contact Sir Ronald Cohen?
Public channels for Sir Ronald Cohen include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Sir Ronald Cohen last invest?
The most recent investment recorded for Sir Ronald Cohen closed in Apr 2026. Shizune tracks 24 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
